LifeCodexx gets go ahead for Down syndrome test in Switzerland

After much controversy, the Swiss national agency for therapeutic products (Swissmedic) has approved PrenaTest, the DNA biomarker prenatal test for Down syndrome, also known as trisomy 21. The test sequences the fetal DNA circulating in the mother's blood. In June, groups representing people with Down syndrome asked the European Court of Human Rights not to recognize individuals' rights to prenatal testing for the condition, claiming that testing leads to almost universal abortions. Article

Suggested Articles

A decade-long study found that patients with early breast cancer may be spared radiation procedures that span the whole breast.

A cell therapy for Parkinson’s disease starts out simple, but quickly gets complicated with the potential for immune responses and cancer mutations.

Johnson & Johnson Vision announced that the worldwide president of its surgical business, Tom Frinzi, plans to retire at the end of this year.